Stifel Nicolaus upgraded Aratana Therapeutics Inc. (Nasdaq: PETX) from a Hold rating to a Buy rating and lifted its price target from $6 to $8. The stock price gained 48 cents to close at $4.35.
Aratana Therapeutics upgraded
March 27, 2018 at 17:21 PM EDT
